Skip to menu Skip to content Skip to footer

2019

Book Chapter

Disease-modifying anti-rheumatic drugs

Pile, Kevin D., Graham, Garry G., Mahler, Stephen M. and Day, Richard O. (2019). Disease-modifying anti-rheumatic drugs. Nijkamp and Parnham’s principles of immunopharmacology. (pp. 709-750) edited by Michael J. Parnham, Frans P. Nijkamp and Adriano G. Rossi. Cham, Switzerland: Springer. doi: 10.1007/978-3-030-10811-3_34

Disease-modifying anti-rheumatic drugs

2018

Book Chapter

Selection of antibodies to transiently expressed membrane proteins using phage display

Jones, Martina L., Mahler, Stephen M. and Kumble, Sumukh (2018). Selection of antibodies to transiently expressed membrane proteins using phage display. Antibody engineering. (pp. 179-195) edited by Damien Nevoltris and Patrick Chames. New York, NY, United States: Springer. doi: 10.1007/978-1-4939-8648-4_10

Selection of antibodies to transiently expressed membrane proteins using phage display

2016

Book Chapter

Interleukin-12/23 Inhibitors: Ustekinumab

Pile, Kevin D., Graham, Garry G. and Mahler, Stephen M. (2016). Interleukin-12/23 Inhibitors: Ustekinumab. Encyclopedia of Inflammatory Diseases. (pp. 1-3) edited by Michael J. Parnham. Basel Switzerland: Springer. doi: 10.1007/978-3-0348-0620-6_232-1

Interleukin-12/23 Inhibitors: Ustekinumab

2015

Book Chapter

Disease-Modifying Anti-Rheumatic Drugs

Pile, Kevin D., Graham, Garry G. and Mahler, Stephen M. (2015). Disease-Modifying Anti-Rheumatic Drugs. Encyclopedia of Inflammatory Diseases. (pp. 1-13) edited by Michael J. Parnham. Basel Switzerland: Springer. doi: 10.1007/978-3-0348-0620-6_48-1

Disease-Modifying Anti-Rheumatic Drugs

2015

Book Chapter

Interleukin-6 Inhibitor – Tocilizumab

Pile, Kevin D., Graham, Garry G. and Mahler, Stephen M. (2015). Interleukin-6 Inhibitor – Tocilizumab. Encyclopedia of Inflammatory Diseases. (pp. 1-5) edited by Michael J. Parnham. Basel Switzerland: Springer. doi: 10.1007/978-3-0348-0620-6_231-1

Interleukin-6 Inhibitor – Tocilizumab

2015

Book Chapter

CD80/CD86 Inhibitors

Pile, Kevin D., Graham, Garry G. and Mahler, Stephen M. (2015). CD80/CD86 Inhibitors. Encyclopedia of Inflammatory Diseases. (pp. 1-4) edited by Michael J. Parnham. Basel Switzerland: Springer. doi: 10.1007/978-3-0348-0620-6_20-1

CD80/CD86 Inhibitors

2015

Book Chapter

CD20 Inhibitors: Rituximab

Pile, Kevin D., Graham, Garry G. and Mahler, Stephen M. (2015). CD20 Inhibitors: Rituximab. Encyclopedia of Inflammatory Diseases. (pp. 1-4) edited by Michael J. Parnham. Basel Switzerland: Springer. doi: 10.1007/978-3-0348-0620-6_21-1

CD20 Inhibitors: Rituximab

2015

Book Chapter

Interleukin 1 Inhibitors

Pile, Kevin D., Graham, Garry G. and Mahler, Stephen M. (2015). Interleukin 1 Inhibitors. Encyclopedia of Inflammatory Diseases. (pp. 1-5) edited by Michael J. Parnham. Basel Switzerland: Springer. doi: 10.1007/978-3-0348-0620-6_29-1

Interleukin 1 Inhibitors

2015

Book Chapter

TNF Inhibitors

Pile, Kevin D., Graham, Garry G. and Mahler, Stephen M. (2015). TNF Inhibitors. Encyclopedia of Inflammatory Diseases. (pp. 1-10) edited by Michael J. Parnham. Basel Switzerland: Springer. doi: 10.1007/978-3-0348-0620-6_67-1

TNF Inhibitors

2012

Book Chapter

Evolution of proteomic methods for analysis of complex biological samples - implications for personalized medicine.

Nouwens, Amanda and Mahler, Stephen (2012). Evolution of proteomic methods for analysis of complex biological samples - implications for personalized medicine.. Integrative Proteomics. (pp. 29-43) edited by Hon-Chiu Eastwood Leung, Tsz-Kwong Man and Ricardo J. Flores. Croatia: InTech. doi: 10.5772/29613

Evolution of proteomic methods for analysis of complex biological samples - implications for personalized medicine.

2011

Book Chapter

C15 disease-modifying antirheumatic drugs

Pile, Kevin D., Graham, Garry G., Mahler, Stephen M. and Day, Richard O. (2011). C15 disease-modifying antirheumatic drugs. Principles of immunopharmacology. (pp. 585-619) edited by Frans P. Nijkamp and Michael J. Parnham. Basel, Switzerland: Springer. doi: 10.1007/978-3-0346-0136-8_30

C15 disease-modifying antirheumatic drugs

1995

Book Chapter

Downstream processing of monoclonal antibodies produced by cell culture techniques

Mahler, S. M. (1995). Downstream processing of monoclonal antibodies produced by cell culture techniques. Fundamental and applied aspects of animal cell culture. (pp. 197-232) edited by J. P. Barford, C. Harbour, C. P. Marquis, R. Malik, S. Mahler and P. J. Phillips. Singapore: Singapore University Press.

Downstream processing of monoclonal antibodies produced by cell culture techniques

1990

Book Chapter

Protein engineering and diagnostic techniques

Mahler, Stephen M. (1990). Protein engineering and diagnostic techniques. Directions in Modern Biotechnology. (pp. 51-71) edited by Pauline M. Doran. Melbourne, VIC, Australia: Hawker Brownlow Education.

Protein engineering and diagnostic techniques